Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Common Stock | Options Exercise | $283K | +10K | +156.69% | $28.32* | 16.4K | Oct 26, 2021 | Direct | F1 |
transaction | MEDP | Common Stock | Sale | -$2.11M | -10K | -61.04% | $211.36 | 6.38K | Oct 26, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MEDP | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -10K | -58.82% | $0.00 | 7K | Oct 26, 2021 | Common Stock | 10K | $28.32 | Direct | F3 |
Id | Content |
---|---|
F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $204.53 to $214.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
F3 | Each option vested on March 15, 2021. |